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Abstract
Background: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an
inherited disease leading to recurrent ischemic stroke and vascular dementia. Numerous mutations in the 23 exons of the
NOTCH3 gene have been reported to cause CADASIL in Caucasian populations, but the full spectrum of genetic changes
leading to this disease is yet to be known and, especially, very few reports are available on CADASIL in Asian populations.
Methods and Results: We genotyped members of a 5-generational Han Chinese family with CADASIL patients and
identified an R133C mutation in the NOTCH3 gene. Clinical analysis demonstrated that the penetrance of the mutation was
not complete. Five of the mutation carriers, not exposed to the known vascular risk factors, did not show any clinical feature
of CADASIL, suggesting the importance of environmental factors to the development of this disease.
Conclusions: Members of a 5-generational Han Chinese family with CADASIL patients had an R133C mutation in the
NOTCH3 gene but only individuals exposed to known vascular risk factors developed CADASIL.
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Introduction
Cerebral autosomal dominant arteriopathy with subcortical
infarcts and leukoencephalopathy (CADASIL) is an inherited
disease with mutations in the NOTCH3 gene [1,2,3]. This
disorder has been found in many race-ethnicities, with most
reported cases coming from European Caucasian families [2,4,5].
To date, very few cases in Asian families have been reported [6],
which however may not necessarily indicate that the disease is rare
in Asia.
The main clinical feature of the disease is the disfunctioning of
the central nervous system (CNS), characterized by recurrent
ischemic attacks or strokes, migraine, cognitive impairment,
dementia and psychiatric disturbances [7]. The mean onset age
is around 45 years old, ranging from 30 to 70 [2,4,5]. About 85%
of symptomatic CADASIL patients have ischemic attacks or stroke
and 22–64% show migraine, which may begin early during
childhood or adolescence but mostly during the third decade
[2,4,6]. Many CADASIL patients also show cognitive decline,
dementia and psychiatric symptoms [6]. In addition to these
common CNS symptoms and signs, some less frequent manifes-
tations of the disease have also been reported, such as epilepsy,
transient disturbances of consciousness, visual impairment, and
hemorrhagic strokes [7,8,9,10].
A large number of mutations in the 23 exons of the NOTCH3
gene have been reported to be associated with CADASIL
[1,5,7,11,12,13,14]. However, the full spectrum of genetic changes
leading to this disease is yet to be known and, especially, very few
reports are available on CADASIL in Asian populations. Here, we
report an R133C mutation on exon 4 of the NOTCH3 gene in
members of a 5-generational Han Chinese family and describe the
unusual clinical manifestations of the disease in this family.
Results
Clinical Data
The proband was a 60-year-old male (II:5; Figure 1), whose
symptoms began at the age of 47. The main clinical manifestations
included mild dysarthria and left central facial and tongue
paralysis. Lower jaw reflex was brisk, bilateral palm-chin reflex
was brisk, bilateral gag reflex was slow, limb tendon reflexes were
brisk, with the lower limbs being pronounced. Left rotation
movement was clumsy, and the Romberg sign was brisk. The
patient had a right hemiparesis.
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signals on the white matter around the ventricles, and punctate
long T1 and long T2 signals in the brainstem (Figure 2). His
intelligence score was normal. Urine routine test, blood glucose,
blood lipids, liver and kidney functions, blood homocysteine
levels, ECG and abdominal ultrasound results were all normal.
This 5-generational family included 6 affected individuals, 72
unaffected individuals, 5 mutation carriers who did not show
symptoms and one large area cerebral infarction patient (II:4),
who was not a CADASIL patient and did not have the
mutation. The main clinical features of the proband and the
other affected individuals in the family were summarized in
Table 1.
NOTCH3 Mutation
Sanger sequencing of the amplified fragments of NOTCH3 in all
affected individuals identified a single base alteration, 475CRT
(Figure 3A, B), in exon 4 of the NOTCH3 gene (GI:4854) located at
19p13.2-p13.1, resulting in the substitution of Arg to Cys at codon
133 (R133C). The remainder of the coding sequence showed no
other changes. Further sequence analysis revealed that all affected
members in this family carried the 475CRT mutation, although 5
mutation carriers did not show symptoms. The other individuals in
this family did not carry this mutation, and the mutation was not
present in 100 normal controls.
Conservation of the Protein in Evolution
Comparison of NOTCH3 protein sequences from six mamma-
lian species by multiple-sequence alignment analysis showed that
the 133Arg residue was located in a highly conserved region of the
protein (Figure 3C).
Discussion
In this study, we identified a mutation, 475CRT (R133C), in
the NOTCH3 gene in a 5-generational Han Chinese family with
CADASIL patients. This mutation co-segregated with the disease
phenotype in all affected individuals except III:4, who was a
patient with massive cerebral infarction but not a CADASIL
patient. The mutation was not present in 100 normal control
subjects. Five members of the family, ?:31, ?:33, ?:34,108 ?28 and
?30, were mutation carriers but did not show any clinical feature of
CADASIL. The result of multiple-sequence alignments showed
that Arg133, mutation of which was previously described by Joutel
[15] and Mykkanen [16], was a conserved residue, indicating its
importance for normal NOTCH3 function.
In this family, the penetrance rate was not 100% in the
mutation carriers, but MRI examination showed that all the
mutation carriers had long T1 and T2 signals within the temporal
lobes and high-intensity signals of FLAIR sequence. However,
III:31, III:33 and III:34 did not show any clinical feature of
CADASIL. One fact worth noting is that these three family
members had not been exposed to any known vascular risk
factors, such as smoking, drinking, and hypertension. On the
other hand, III:5, III:32 and IV:13, who showed very evident
clinical features, had obviously contacted vascular risk factors,
such as smoking or hypertension. The genotype–phenotype
correlation in CADASIL has not been clarified. Although some
data support genotype–phenotype correlation in CADASIL
[7,13,17,18], the mutation found in patients of the family did
not have specific effects on the expressivity of the disease. Some
authors report that vascular risk factors [19,20] or other
unexplored factors may influence the phenotypic variability and
lead to atypical features of the CADASIL patients, which may
explain why III:31, III:33 and III:34 did not show any clinical
feature of CADASIL. However, correlations between vascular
risk factors and expressivity of the disease would require larger
scales of study involving many more patients and controls for a
conclusion.
NOTCH3 (N3) is one member of the Notch receptor
superfamily, which regulates cell fate during embryonic develop-
ment [21] and is predominantly expressed in vascular smooth
muscle cells (VSMC) in adulthood [1,22]. Appropriately half of
identified CADASIL-related mutations are located on exons 2–4
[7,11], which encode the extracellular domain of N3 (N3
ECD)
within epidermal growth factor-like (EGF-like) repeat domains
[15,23,24]. Modular structures show that six highly conserved
cysteine residues within these domains stabilize the domain [25].
Dichgans and colleagues, by blocking or facilitating disulfide
bridge formation, found that multimerization of N3, at least in
part, depends on disulfide bridges and unpaired cysteine residue
might make CADASIL-mutated N3
ECD more susceptible to
multimerization in higher order complexes [26].
Figure 1. Pedigree of a 5-generational Chinese Han family affected with CADASIL. Squares and circles indicate males and females,
respectively. Filled symbols denote affected status. Normal individuals are shown as empty symbols. Mutation carriers without evident clinical
features are indicated by a circle with a vertical line in the middle (III:31, III:33, III:34, IV:30) or a square with a vertical line in the middle (IV:28). II:4 had
a large area cerebral infarction but was not a CADASIL patient.
doi:10.1371/journal.pone.0036590.g001
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PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e36590In summary, this study identified the 475CRT (R133C)
mutation in the NOTCH3 gene in a 5-generational Han Chinese
family with CADASIL. Five family members were not exposed to
any vascular risk factors and they did not show any clinical feature
of CADASIL. Vascular risk factors may play a vital role in the
development of CADASIL.
Figure 2. Cerebral MRI examination in the CADASIL family members. II:5, the proband, was a 60-year-old male affected family member.
III:31, III:32, III:33 and III:34 were the children of the proband (II:5). II:5 and III:32 showed evident clinical features, but III:31, III:33 and III:34 did
not show any clinical feature, although they were all mutation carriers (see the long T1 and T2 signals). III:25, III:15, IV:25, IV:10 and IV:11 were
healthy core family members. III:4 is a patient with l massive cerebral infarction, who did not have the R133C mutation.
doi:10.1371/journal.pone.0036590.g002
Table 1. Clinical features of the affected individuals.
Patient Sex Age Onset Age Migraine Memory MRI Examination
Vascular Risk
Factors Other Symptom
II:4 F 67 48 – Severe Gliosis in the left
temporal lobe, forehead
and parietal
lobe; massive
cerebral
infarction
– Ineffective activity of
right limbs accompanied
by verbal clumsiness
for over 20 years;
obvious memory
decline; no
dysphagia or dysuria.
II:5 M 60 47 – Mild Long T1 and
T2 signals shown
on the white
matter around the
ventricles; punctuate
long T1 and
long T2
signals in the brainstem;
CADASIL patient.
Smoking Unsteady gait for
2 months, getting
worse for
1 week; numbness
in hands and
feet; language
unclear; ataxia;
lower extremity
weakness.
III:32 M 40 30 + Mild Punctate long
T1 and long
T2 signals on
the temporal lobes;
bilateral basal ganglia
and corona radiate
and high-intensity
signals of FLAIR
sequence; CADASIL patient.
Smoking Numbness in hands
and feet; no
symptoms of
ineffective activity
of the limbs,
memory decline
or headache.
IV:13 M 31 20 + Mild Punctate long T1
and T2 signals on
right hemisphere of
cerebellum, bilateral temporal
lobes, bilateral basal
ganglia and corona
radiate, high-intensity
signals of FLAIR
sequence; CADASIL
patient.
Hypertension Drowsiness
accompanied by
paroxysmal hemicrania for
over 10 years;
headache during the
course of the
disease; MMSE
score 29.
III:31 F 41 – – – Abnormal punctate long
T1 and T2
signals on bilateral
frontal lobes, slightly
higher signal intensity
of lesions on
FLAIR;
CADASIL patient.
––
III:34 F 36 – – – Abnormal punctate long T1 and
long T2 signal shown on bilateral
frontal lobe; CADASIL patient.
––
III:33 F 36 – – – Punctate long T1
and long T2
signals on bilateral
temporal lobes,
bilateral basal ganglia
and corona radiate;
CADASIL patient.
––
doi:10.1371/journal.pone.0036590.t001
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Affected and Unaffected Individuals in the Family
We ascertained a 5-generational Chinese Han family with non-
syndromic CADASIL (see Figure 1) at the Second Affiliated
Hospital of Harbin Medical University, Harbin, China. Informed
consent was obtained from each participant, consistent with the
Declaration of Helsinki. We recorded their medical history in
detail. Physical and MRI examination was carried on each of the
family members. Genomic DNA was extracted from peripheral
blood leukocytes using standard protocols.
DNA sequencing
Individual exons of NOTCH3 were amplified by PCR using
primer pairs shown in Table S1. The PCR products were
sequenced on an ABI3130 Automated Sequencer.
Multiple Sequence Alignment
From the NCBI website (http://www.ncbi.nlm.nih.gov/), the
NOTCH3 protein sequence of various species were obtained and,
by using the Vector NTI software, multiple-sequence alignments
of NOTCH3 proteins were carried out.
Supporting Information
Table S1 PCR primers and PCR product sizes for
NOTCH3 sequence analysis.
(DOC)
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Figure 3. Analysis of the DNA and protein sequences. DNA sequence chromatogram of the R133C mutation in NOTCH3 and multiple-sequence
alignment of NOTCH3 protein family. The CRT transition at position 475 resulting in the R133C mutation is located within a highly conserved region.
A: DNA sequence chromatogram of the unaffected family members and III:4; B: DNA sequence chromatogram of the affected family members and
III:31 and III:33; C: multiple-sequence alignment of NOTCH3 protein family.
doi:10.1371/journal.pone.0036590.g003
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